These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30693700)

  • 1. [Progress on cancer associated fibroblasts in tumor immunoregulation].
    Li G; He J; Wang Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):558-563. PubMed ID: 30693700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
    Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
    Front Immunol; 2021; 12():671595. PubMed ID: 34305902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
    Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
    Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research Status of Tumor-associated Fibroblasts Regulating Immune Cells].
    Mu G; Zhang W; Huang J; Chen Z; Wang J
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):207-213. PubMed ID: 35340164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
    Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
    Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
    Harper J; Sainson RC
    Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer associated fibroblasts: is the force the path to the dark side?
    Barbazán J; Matic Vignjevic D
    Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
    Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
    Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
    Ai W; Liu T; Lv C; Feng X; Wang Q
    Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.
    An Y; Liu F; Chen Y; Yang Q
    J Cell Mol Med; 2020 Jan; 24(1):13-24. PubMed ID: 31642585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
    De Jaeghere EA; Denys HG; De Wever O
    Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer.
    Zhang Z; Zhang H; Shi L; Wang D; Tang D
    Immunology; 2022 Sep; 167(1):1-14. PubMed ID: 35569095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAFs and T cells interplay: The emergence of a new arena in cancer combat.
    Chen M; Chen F; Gao Z; Li X; Hu L; Yang S; Zhao S; Song Z
    Biomed Pharmacother; 2024 Aug; 177():117045. PubMed ID: 38955088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of tumour microenvironment in the progression and development of oral cancer.
    Mughees M; Sengupta A; Khowal S; Wajid S
    Mol Biol Rep; 2021 Feb; 48(2):1773-1786. PubMed ID: 33492572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts.
    Ziani L; Chouaib S; Thiery J
    Front Immunol; 2018; 9():414. PubMed ID: 29545811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy.
    Liao Z; Tan ZW; Zhu P; Tan NS
    Cell Immunol; 2019 Sep; 343():103729. PubMed ID: 29397066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.